CityshrimpMEnglish · 2 years agoGeneral Chat pinmessage-squaremessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1message-squareGeneral Chat pinCityshrimpMEnglish · 2 years agomessage-square0fedilink
CityshrimpMEnglish · edit-22 years agoCheat Sheetplus-squarepinmessage-squaremessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1message-squareCheat Sheetplus-squarepinCityshrimpMEnglish · edit-22 years agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 2 years agoBiora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platforminvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up12arrow-down10
arrow-up12arrow-down1external-linkBiora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platforminvestors.bioratherapeutics.comCityShrimp@lemmy.sdf.orgEnglish · 2 years agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 2 years agoBiora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conferenceinvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up13arrow-down10
arrow-up13arrow-down1external-linkBiora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conferenceinvestors.bioratherapeutics.comCityShrimp@lemmy.sdf.orgEnglish · 2 years agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 2 years agoBiora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platforminvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkBiora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platforminvestors.bioratherapeutics.comCityShrimp@lemmy.sdf.orgEnglish · 2 years agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 2 years agoJuly 2023 Corporate Presentationinvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up12arrow-down10cross-posted to: biora
arrow-up12arrow-down1external-linkJuly 2023 Corporate Presentationinvestors.bioratherapeutics.comCityShrimp@lemmy.sdf.orgEnglish · 2 years agomessage-square0fedilinkcross-posted to: biora
CityshrimpMEnglish · 2 years agoBiora Therapeutics Continues to Monetize Legacy Diagnostics Assetsplus-squareinvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkBiora Therapeutics Continues to Monetize Legacy Diagnostics Assetsplus-squareinvestors.bioratherapeutics.comCityshrimpMEnglish · 2 years agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 2 years agoTesting post from a different instance message-squaremessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1message-squareTesting post from a different instance CityShrimp@lemmy.sdf.orgEnglish · 2 years agomessage-square0fedilink
CityshrimpMEnglish · 2 years agoBiora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform investors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkBiora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform investors.bioratherapeutics.comCityshrimpMEnglish · 2 years agomessage-square0fedilink
